Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation

Immunology

Volumn 90, Issue 3, 1997, Pages 388-396

  Allende, L M ^a   Corell, A ^a   Madrono A ^b   Gongora R ^b   Rodriguez Gallego C ^b   Lopez Goyanes A ^b   Rosal, M ^b   Arnaiz Villena, A ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMINOL; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; RETINOIC ACID; RETINOL; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031040601     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1997.00388.x     Document Type: Article

References (51)

1. BROCKES J. (1990) Reading the retinoid signals. Nature 345, 766.
2. MADEN M. (1994) The retinoic acid supergun affair. Curr Biol 4, 281.
3. VOLLBERG T.M., NERVI C., GEORGE M.D., FUGIMOTO W., KRUST A. & JETTEN A.M. (1992) Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol 6, 667.
4. ROSS C. & TERNUS M.E. (1993) Vitamin A as a hormone: recent advances in understanding the actions of retinol, retinoic acid and beta carotene. J Am Diet Assoc 93, 1285.
5. FORMELLI F., CARSANA R., COSTA A. et al. (1989) Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 49, 6149.
6. SAXON A., KELD B., BRAUN J., DOTSON A. & SIDELL N. (1993) Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display and in vitro and in vivo B-cell antibody production. Immunology 80, 477.
7. ZITNIK R., KOTLOFF R.M., LATIFPOUR J. et al. (1994) Retinoic acid inhibition of IL-1 induced IL-6 production by human lung fibroblasts. J Immunol 152, 1419.
8. BLOMHOFF R., GREEN M.H., BERG T. & NORUM K.R. (1991) Vitamin A metabolism: new perspectives on absorption, transport and storage. Physiol Rev 71, 952.
9. BLOMHOFE R., GREEN M.H., BERG T. & NORUM K.R. (1990) Transport and storage of vitamin A. Science 250, 399.
10. CHAMBON P., ZELENT A., PETKOVICH M. et al. (1991) The family of retinoic acid nuclear receptors. In: Retinoids: 10 Years on. (ed. J. H. Sourat), p.10. Karger, Basel.
11. BLUMBERG B., MANGELSDORF D.J., DYCK J.A., BITTNER D.A., EVANS R.M. & DE ROBERTIS E. (1992) Multiple retinoid-responsive receptors in a single cell: families of RXRs and RARs in the Xenopus egg. Proc Natl Acad Sci USA 89, 2321.
12. LEID M., KASTNER P., LYONS R. et al. (1992) Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377.
13. EVANS R. (1988) The steroid and thyroid hormone receptor family. Science 240, 889.
14. BEATO M. (1989) Gene regulation by steroid hormones. Cell 56, 335.
15. MOORE D.D. (1990) Diversity and unity in the nuclear hormone receptors: a terpenoid receptor superfamily. The New Biologist 2, 100.
16. LOHNES D., DIERICH A., GHYSELINCK N. et al. (1990) Retinoid receptors and binding proteins. J Cell Sci 16, 69.
17. 3 receptors. Cell 65, 1255.
18. MANGELSDORF D.J., UMESONO K., KLIEWER S.A., BORGMEYER U., ONG U.S. & EVANS R.M. (1991) A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66, 555.
19. SEMBA R.D. (1994) Vitamin A, immunity and infection. Clin Infect Dis 9, 489.
20. VILLA M.L., FERRARIO E., TRABATTONI D. et al. (1993) Retinoids. breast cancer and NK cells. Br J Cancer 68, 845.
21. BLOMHOFF H.K., SMELAND F.B. & ERIKSTEIN B. (1992) Vitamin A is a key regulator for cell growth, cytokine production and differentiation in normal B cells. J Biol Chem 267, 3988.
22. GARBE A., BUCK J. & HÄMMERLING U. (1992) Retinoids are important cofactors in T cell activation. J Exp Med 176, 109.
23. SEMBA R.D., MUHILAL, WARD B.J. et al. (1993) Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 341, 5.
24. SIDELL N., CHANG B. & BHATTI L. (1993) Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cell Immunol 146, 28.
25. YANG Y., VACCHIO M. & ASHWELL J. (1993) 9-cis retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. J Proc Natl Acad Sci USA 90, 6170.
26. BISSONNETTE R., BRUNNER T., LAZARCHIK S. et al. (1995) 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol 15, 5576.
27. IWATA M., MUKAI M., NAKAI Y. & ISEKI R. (1992) Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J Immunol 149, 3302.
28. YANG Y., MERCEP M., WARE C. & ASHWELL J. (1995) Fas and activation-induced Fas-ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 181, 1673.
29. YANG Y., MINUCCI S., OZATO K., HEYMAN R. & ASHWELL J. (1995) Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem 270, 18672.
30. FRIEDMAN A., HALEVY O., SCHRIFT M., ARAZI Y. & SKLAN D. (1993) Retinoic acid promotes proliferation and induces expression of retinoic acid receptor-α gene in murine T lymphocytes. Cell Immunol 152, 240.
31. ABB J. & DEINHARDT F. (1980) Effects of retinoic acid on the human lymphocyte response to mitogens. Exp Cell Biol 48, 169.
32. REGUEIRO J.R., LÓPEZ-BOTET M., LANDÁZURI M.O. et al. (1987) An in vivo immune system lacking polyclonal T cell surface expression of the CD3/Ti (WT31) complex. Scand J Immunol 26, 699.
33. NICOLETTI I., MIGLIORATI G., PAGLIACCI M.C., GRIGNANI F. & RICCARDI C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271.
34. PÉREZ-ACIEGO P., ALARCÓN B., ARNAIZ-VILLENA A. et al. (1991) Expression and function of a variant T cell receptor complex lacking CD3γ. J Exp Med 174, 319.
35. PÉREZ-BLAS M., ARNAIZ-VILLENA A., GÓNGORA R., SEGURADO O., VIVANCO J.L. & REGUEIRO J.R. (1991) Impaired T cell signal transduction through CD28 in a patient with idiopathic thrombocytopenia. Clin Exp Immunol 85, 424.
36. +) T lymphocytes in Papillon-Lefèvre syndrome. Hum Immunol 41, 185.
37. SIDELL N. & RAMSDELL F. (1988) Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 115, 299.38.
38. AGURA E.D., HOWARD M. & COLLINS S.J. (1992) Identification and sequence analysis of the promoter for the leukocyte integrin β-subunit (CD18): a retinoic acid inducible gene. Blood 79, 602.
39. CANTORNA M.T., NASHOLD F.E. & HAYES C.E. (1994) In vitamin-A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152, 1515.
40. CARMAN J.A. & HAYES C.A. (1991) Abnormal regulation of IFN-γ secretion in vitamin A deficiency. J Immunol 147, 1247.
41. RACKE M.K., BURNETT D., PAK S.H. et al. (1995) Retinoid treatment of experimental allergie encephalomyelitis, IL-4 production correlates with improved disease course. J Immunol 154, 450.
42. SIDELL N., FAMATIGA L. & GOLUB S.H. (1981) Augmentation of human thymocyte proliferative responses by retinoic acid. Exp Cell Biol 49, 239.
43. REGUEIRO J.R., RODRÍGUEZ-GALLEGO C. & ARNAIZ-VILLENA A. EDS. (1994) Human T Lymphocyte Activation Deficiencies, p.22. CRC Press, CA.
44. BIESINGER B., MÜLLER-FLECKENSTEIN I., SIMMER B. et al. (1992) Stable growth transformation of human T lymphocytes by Herpes virus saimiri. Proc Natl Acad Sci USA 89, 3116.
45. GOODMAN D.S. (1984) Vitamin A and retinoids in health and disease. N Engl J Med 310, 1023.
46. CLAMON G., CHABOT G.G., VALERIOTE F. et al. (1985) Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid. Cancer Res 45, 1874.
47. CASTAIGNE S., CHOMIENNE C., DANIEL M.T. et al. (1990) All-transretinoic acid as a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 76, 1704.
48. NEY U.M., BALL I.J., HILL R.P., WESTMACOTT D. & BLOXHAM D.P. (1987) Anti-inflammatory effects of synthetic retinoids may be related to their immunomodulatory action. Dermatologica 175, 81.
49. MEUNIER L., BOHJANEN K., WOORHEES J.J. & COOPER K.D. (1994) Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CDI le, a beta 2 integrin critically involved in T-cell activation. J Invest Dermatol 103, 775.
50. COPE F.O., HOWARD B.D. & BOUTWELL R.K. (1986) The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors. Experimentia 42, 1023.
51. FANJUL A., DAWSON M.I., HOBBS P.D. et al. (1994) A new class of retinoids with selective inhibition of AP-I inhibits proliferation, Nature 372, 107.